Physician profile
Srihari Narayanan
NPI 1194916353
$2,095.33
in general payments reported to CMS, 2019-2025
10 companies · $526 in 2025
The $526 reported for 2025 was more than what 78% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $150 · 2021: $454 · 2022: $300 · 2023: $216 · 2024: $300 · 2025: $526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $500 · Food and Beverage: $292 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $500.00 |
| Food and Beverage | $291.58 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $550.00 | 2019-2025 | Air Optix |
| Coopervision INC. | $550.00 | 2019-2025 | Clariti Contact Lens |
| Johnson & Johnson Vision Care, INC. | $500.00 | 2020-2025 | Acuvue |
| Novartis Pharmaceuticals Corporation | $130.12 | 2021 | |
| Glaukos Corporation | $95.30 | 2025 | Kxl System (Not Refurbished), Photrexa Viscous and Photrexa |
| Bausch & Lomb Americas INC. | $66.09 | 2025 | Xiidra, Scoutpro Osmolarity System |
| Abbvie INC. | $65.91 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $64.28 | 2025 | |
| Allergan, INC. | $50.24 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $23.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Srihari Narayanan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.